Art Unit 1619
Group 1610Pharmaceutical and Agricultural Compositions
- Active examiners
- 19
- Average office actions per grant
- 2.96
Grant ratio
- Art Unit 1619
- 32.8%
- Group 1610
- 42.8%
Active examiners
| Tigabu Kassa | 31.5% | 3.40 | October 2026 |
|---|---|---|---|
| Sarah Al-Awadi | 33.3% | 3.09 | October 2026 |
| Ivan Greene | 15.7% | 3.36 | October 2026 |
| Thurman Wheeler | 41.5% | 3.21 | October 2026 |
| Sarah Chickos | 36.2% | 3.15 | October 2026 |
| Garen Gotfredson | 34.0% | 3.28 | October 2026 |
| Nicole Plourde Babson | 38.0% | 3.04 | October 2026 |
| Alissa Prosser | 14.0% | 3.28 | October 2026 |
| Lori K Mattison | 12.5% | 3.42 | October 2026 |
| Daniel F. Coughlin | 32.5% | 3.32 | October 2026 |
| John P Nguyen | 38.9% | 2.71 | October 2026 |
| Edwin C Mitchell | 16.0% | 2.44 | October 2026 |
| Sean J. Steinke | 0.0% | N/A | October 2026 |
| Shanon A. Foley | 46.1% | 1.68 | October 2026 |
| Kaeleigh Elizabeth Olsen | 3.6% | 1.00 | October 2026 |
| Matthew Ryan Burke | 0.0% | N/A | October 2026 |
| Brian Gulledge | 0.0% | 2.60 | October 2026 |
| Jennifer A Berrios | 10.0% | 2.73 | October 2026 |
| Liliana Cerullo | 0.0% | 1.00 | October 2026 |
Examiner distribution
- Median grant ratio
- 23.8%
- Middle 50% of grant ratios
- 10.6%–35.6%
- Median office actions / grant
- 3.12
- Middle 50% of office actions / grant
- 2.68–3.29
Active examiners with at least 20 applications.
Other associated examiners
Examiners without recent activity.
| Jyothsna Venkat | 56.5% | 2.38 | August 2023 Appears inactive |
|---|---|---|---|
| Suzanne Ziska | 55.7% | 2.75 | December 2023 Appears inactive |
| Devang Thakor, Ph.D | 34.2% | 2.95 | August 2020 Appears inactive |
| Christopher R. Lea | 22.6% | 2.24 | August 2013 Appears inactive |
| Donna Jagoe | 17.9% | 2.27 | August 2010 Appears inactive |
| David J. Blanchard | 20.0% | 1.93 | May 2026 Potentially inactive |
| Tracey Simmons Willis | 5.9% | 2.50 | November 2009 Appears inactive |
| Raymond P. Yeager | 0.0% | 1.00 | November 2009 Appears inactive |
| Tracey Simmons Willis | 0.0% | N/A | October 2009 Appears inactive |
Based on available public USPTO records; may be incomplete.